Abstract
Sudden cardiac death (SCD) is defined as natural death from cardiac causes heralded by an abrupt loss of consciousness within one hour of the onset of acute symptoms (13). SCD claims more than 300,000 Americans each year and is the leading cause of cardiovascular death in Western societies. It is important to note that SCD is caused by rapid ventricular arrhythmias such as ventricular tachycardia (VT) or fibrillation (VF) that often occur without warning. The majority of patients who succumb to SCD do not have previously recognized arrhythmias and, therefore, are not known to be at high risk until after a catastrophic arrhythmic event has occurred when it is often too late. Consequently, it is of tantamount importance for physicians to identify, a priori, those patients at greatest risk for SCD so that appropriate clinical interventions can be made. Unfortunately, noninvasive techniques used previously to identify high-risk patients such as the signal average electrocardiograph (11,23), Holter monitoring (12), heart rate variability (9), and QT dispersion (2,26) have not demonstrated sufficient predictive accuracy to justify invasive electrophysiological testing or therapies in otherwise asymptomatic patients (i.e., before they experience a major clinical event) based on a positive result from one or more of these tests.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adam D, Smith J, Akselrod S, Nyberg S, Powell A, Cohen R. Fluctuations in T-wave morphology and susceptibility to ventricular fibrillation. J Electrocardiol. 1984;17:209–218.
Barr CS, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden unexpected death in chronic heart failure. Lancet. 1994;343:327–329.
Cheng TC. Electrical alternans: An association with coronary artery spasm. Arch Inter Med. 1983;143:1052–1053.
Dilly SG, Lab MJ. Electrophysiological alternans and restitution during acute regional ischemia in myocardium of anesthetized pig. J.Physiol (Lond). 1988;402:315–333.
Hamburger WW, Katz LN, Saphir L. Electrical alternans, clinical study with report of two necropsies. JAMA. 1936;106:902–905.
Heijima K, Sano T. Electrical alternans of the TU wave in Romano-Ward syndrome. Br Heart J. 1976;38:767–770.
Hellerstein HK, Leibow IM. Electrical alternation in experimental coronary artery occlusion. Am J Physiol. 1950;160:366–374.
Joyal M, Feldman RL, Pepine CJ. ST-segment alternans during percutaneous transluminal coronary angioplasty. Am J Cardiol. 1984;54:915–916.
Kleiger RE, Miller JP, Bigger JT, Moss AJ. Multicenter post-infarction research group: Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59:256–262.
Kleinfeld MJ, Rozanski JJ. Alternans of the ST-segment in Prenzmetal’s angina. Circulation. 1977;55:574–577.
Kuchar D, Thorburn C, Sammel N. Late potentials detected after myocardial infarction: Natural history and prognostic significance. Circulation. 1986;74:1280–1289.
Moss AJ. Clinical significance of ventricular arrhythmias in patients with and without coronary artery disease. Prog Cardiovasc Dis. 1980;23:33–52.
Myerburg RJ, Kessler KM, Interian A Jr, Fernandez P, Kimura S, Kozlovskis PL, Furukawa T, Bassett AL, Castellanos A. Clinical and experimental pathophysiology of sudden cardiac death. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology from Cell to Bedside. Philadelphia: WB Saunders; 1990: 675.
Nearing B, Huang AH, Verrier RL. Dynamic tracking of cardiac vulnerability by complex demodulation of the T-wave. Science. 1991;252:437–440.
Nearing BD, Verrier RL. Personal computer system for tracking cardiac vulnerability by complex demodulation of the T wave. J.Appl Physiol. 1993;74:2606–2612.
Platt SB, Vijgen JM, Albrecht P, Van Hare GF, Carlson MD, Rosenbaum DS. Occult T wave alternans in long QT syndrome. J.Cardiovasc Electrophysiol. 1996;7:144–148.
Puletti M, Curione M, Righetti G, Jacobellis. Alternans of the ST-segment and T-wave in acute myocardial infarction. J. Electrocardiol. 1980;13:297–300.
Rosenbaum DS, Albrecht P, Cohen RJ. Predicting sudden cardiac death from T wave alternans of the surface electrocardiogram: Promise and pitfalls. J.Cardiovasc Electrophysiol. 1996;7:1095–1111.
Rosenbaum DS, Bin H, Cohen RJ. New approaches for evaluating cardiac electrical activity: Repolarization alternans and body surface Laplacian mapping. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia: WB Saunders; 1994:1187–1197.
Rosenbaum DS, Jackson LE, Smith JM, Garan H, Ruskin JN, Cohen RJ. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med. 1994;330:235–241.
Rubenstein DS, Lipsius SL. Premature beats elicit a phase reversal of mechanoelectrical alternans in cat ventricular myocytes: A possible mechanism for reentrant arrhythmias. Circulation. 1995;91:201–214.
Schwartz PJ, Malliani A. Electrical alternation of the T-wave: Clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long QT syndrome. Am Heart J. 1975;89:45–50.
Simson MB. Identification of patients with ventricular tachycardia after myocardial infarction from signals in the terminal QRS complex. Circulation. 1981;64:235–242.
Smith JM, Clancy EA, Valeri R, Ruskin JN, Cohen RJ. Electrical alternans and cardiac electrical instability. Circulation. 1988;77:110–121.
Verrier RL, Nearing BD. Electrophysiologic basis for T wave alternans as an index of vulnerability to ventricular fibrillation. J.Cardiovasc Electrophysiol. 1994;5:445–461.
Zareba W, Moss AJ, Le Cessie S. Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. Am J Cardiol. 1994;74:550–553.
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Rosenbaum, D.S. (1998). Microvolt-Level T-Wave Alternans as a Marker of Vulnerability to Cardiac Arrhythmias: Principles and Detection Methods. In: Analysis and Assessment of Cardiovascular Function. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-1744-2_18
Download citation
DOI: https://doi.org/10.1007/978-1-4612-1744-2_18
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-7261-8
Online ISBN: 978-1-4612-1744-2
eBook Packages: Springer Book Archive